Galectin Announces First Patient Dosed in Phase 1 Trial of GR-MD-02; Targeted Medical Pharma Completes Middle East Distribution Agreement

Print E-mail
By Mary Davila   
Thursday, 17 April 2014 19:12
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 17, 2014.
Read more...
 

Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11; Cleveland Biolabs Successfuly Close of Phase 1 Study of CBL0102

Print E-mail
By Staff and Wire Reports   
Wednesday, 16 April 2014 18:19
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 16, 2014.
Read more...
 

Healthcare Review: Verde Media Group, Apricus Biosciences, Zalicus, Quintiles Transnational, ConMed

Print E-mail
By Staff and Wire Reports   
Wednesday, 16 April 2014 12:37
U.S. stocks gained broadly on Wednesday, as rising hopes of economic stimulus from Asia helped boost investor confidence.
Read more...
 

Boston Scientific Reports FDA Approval for Heart Failure Devices; Teva Unveils Generic Lunesta Tablets in US

Print E-mail
By Staff and Wire Reports   
Tuesday, 15 April 2014 18:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 15, 2014.
Read more...
 

Healthcare Review: Tekmira Pharmaceuticals, Herbalife, Halozyme, WebMD, Akorn

Print E-mail
By Staff and Wire Reports   
Tuesday, 15 April 2014 13:27
The Standard & Poor’s 500 Index erased losses as investors weighed corporate earnings, weaker-than-estimated economic data and tensions in Ukraine.
Read more...
 

Bristol-Myers Squibb Submits NDA to FDA for Fixed-Dose Combo Tablet; pSivida Announces PDUFA Date for ILUVIEN

Print E-mail
By Staff and Wire Reports   
Monday, 14 April 2014 19:58

Below is a look at some of the headlines for companies that made news in the healthcare sector on April 14, 2014.

Read more...
 

Healthcare Review: Dicerna Pharmaceuticals, HMS Holdings, , CEL-SCI Corp, Depomed, Intercept Pharmaceuticals

Print E-mail
By Staff and Wire Reports   
Monday, 14 April 2014 13:14
Stocks rebounded on Monday after a bigger-than-expected rise in March retail sales offered a sign that economic growth was on better footing following a difficult winter.
Read more...
 

Impax Pharma Resubmits RYTARY Extended-Release Capsules to FDA; Dendreon Phase II STAND Study Will Be Presented at EAU Congress

Print E-mail
By Staff and Wire Reports   
Friday, 11 April 2014 19:29
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 11, 2014.
Read more...
 

Healthcare Review: Gilead Sciences, Impax Pharmaceuticals, AbbVie, Creative Edge Nutrition, Regado Biosciences

Print E-mail
By Staff and Wire Reports   
Friday, 11 April 2014 13:08
U.S. stocks were set for a lower open on Friday after earnings from JP Morgan Chase, putting the S&P 500 on track to continue its selloff after suffering its biggest drop in two months.
Read more...
 

Spectranetics Announces FDA Clearance for Mechanical Lead Extraction Devices; Celladon Receives Breakthrough Therapy Designation for MYDICAR

Print E-mail
By Staff and Wire Reports   
Thursday, 10 April 2014 20:01
Below is a look at some of the headlines for companies that made news in the healthcare sector on April 10, 2014.
Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 331
BioMedReports Galectin Announces First Patient Dosed in Phase 1 Trial of GR-MD-02; Targeted Medical Pharma Completes Middle ... http://t.co/ia50TaWnPa
18hreplyretweetfavorite
BioMedReports Key milestone for brown fat research with a ground-breaking MRI scan http://t.co/MQTeFGrMOj
BioMedReports Baxter Announces Primary Efficacy Endpoint for Phase 3 Trial of BAX 11; Cleveland Biolabs Successfuly Close of... http://t.co/vhI1HwOLoB
navigation
Benzinga.com supporter Seeking Alpha Certified